Organon & Co. 8-K

What Happened

• On February 12, 2026, Organon & Co. announced its financial results for the quarter and full year ended December 31, 2025 via a press release and accompanying investor materials. The press release was furnished as Exhibit 99.1 to the Form 8‑K, and the Company Information Presentation for the related conference call was made available on Organon’s investor relations website and furnished as Exhibit 99.2. The disclosure was made under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).

Key Details

• Filing date: February 12, 2026.
• Reporting period: quarter and full year ended December 31, 2025.
• Exhibit 99.1: Earnings press release announcing the results.
• Exhibit 99.2: Company Information Presentation posted at https://www.organon.com and used for the conference call.

Why It Matters

• This 8‑K is the company’s official public release of its most recent earnings and related investor materials—critical sources for investors tracking revenue, earnings, cash flow, guidance, and management commentary. The presentation and press release will be used by analysts and shareholders to update financial models and investment decisions. Because the materials were posted publicly and furnished under Regulation FD, all investors have equal access to the same information ahead of the company’s conference call. Review the attached press release and slide deck for the specific financial figures and management discussion.